<output id="zjvxt"><video id="zjvxt"></video></output>

<video id="zjvxt"><delect id="zjvxt"><font id="zjvxt"></font></delect></video><font id="zjvxt"></font>

<p id="zjvxt"><output id="zjvxt"><delect id="zjvxt"></delect></output></p>

<p id="zjvxt"><output id="zjvxt"><delect id="zjvxt"></delect></output></p>
<noframes id="zjvxt">
<output id="zjvxt"></output><p id="zjvxt"></p>
<output id="zjvxt"></output>

<p id="zjvxt"></p>
<p id="zjvxt"></p>

<p id="zjvxt"></p>
<video id="zjvxt"><output id="zjvxt"></output></video>
<output id="zjvxt"><delect id="zjvxt"></delect></output>
<video id="zjvxt"><output id="zjvxt"></output></video>

<video id="zjvxt"></video>

<p id="zjvxt"><output id="zjvxt"></output></p>

<video id="zjvxt"><output id="zjvxt"></output></video><video id="zjvxt"></video>
<output id="zjvxt"><output id="zjvxt"></output></output>
<p id="zjvxt"><delect id="zjvxt"><font id="zjvxt"></font></delect></p>

<p id="zjvxt"><delect id="zjvxt"><font id="zjvxt"></font></delect></p>
<video id="zjvxt"></video><p id="zjvxt"></p>
<video id="zjvxt"><output id="zjvxt"><delect id="zjvxt"></delect></output></video>

<video id="zjvxt"><output id="zjvxt"></output></video>
<p id="zjvxt"><delect id="zjvxt"></delect></p>

<output id="zjvxt"><output id="zjvxt"></output></output><output id="zjvxt"></output>
<p id="zjvxt"><output id="zjvxt"></output></p>
<p id="zjvxt"></p>
<p id="zjvxt"></p>

武漢先路醫藥科技股份有限公司歡迎您的光臨Welcome !
?
?
當前位置:首頁 > 新聞中心 > 行業動態

關于公開征求《溶瘤病毒產品藥學研究與評價技術指導原則(征求意見稿)》意見的通知

來源:NMPA CDE  發布時間:2021-04-30  瀏覽量:451

關于公開征求《溶瘤病毒產品藥學研究與評價技術指導原則(征求意見稿)》意見的通知

發布日期:20210430

      為規范和指導溶瘤病毒產品的研發、申報和評價,我中心在前期調研的基礎上,結合國內外相關法規和技術要求,以及對這類產品當前技術發展和科學認知,形成了《溶瘤病毒產品藥學研究與評價技術指導原則(征求意見稿)》?,F通過中心網站向社會公開征求意見,誠摯歡迎社會各界對征求意見稿提出寶貴意見和建議,請在征求意見反饋表填寫具體信息,并通過郵件反饋我們。感謝您的參與和支持!
       征求意見時限為自發布之日起一個月。
       聯系人:崔靖,Email:cuijing@cde.org.cn;
                     韋薇,Email:weiw@cde.org.cn;
                                                                                                                           國家藥品監督管理局藥品審評中心
                                                                                                                                         2021年4月30日

       附件1:《溶瘤病毒產品藥學研究與評價技術指導原則(征求意見稿)》

       附件2:《溶瘤病毒產品藥學研究與評價技術指導原則(征求意見稿)》起草說明

       附件3:《溶瘤病毒產品藥學研究與評價技術指導原則(征求意見稿)》反饋表

?
網站首頁| 關于先路| 產品中心| 研發體系| 合作伙伴| 新聞中心| 職業機會| 聯系我們
国产一级黄片

<output id="zjvxt"><video id="zjvxt"></video></output>

<video id="zjvxt"><delect id="zjvxt"><font id="zjvxt"></font></delect></video><font id="zjvxt"></font>

<p id="zjvxt"><output id="zjvxt"><delect id="zjvxt"></delect></output></p>

<p id="zjvxt"><output id="zjvxt"><delect id="zjvxt"></delect></output></p>
<noframes id="zjvxt">
<output id="zjvxt"></output><p id="zjvxt"></p>
<output id="zjvxt"></output>

<p id="zjvxt"></p>
<p id="zjvxt"></p>

<p id="zjvxt"></p>
<video id="zjvxt"><output id="zjvxt"></output></video>
<output id="zjvxt"><delect id="zjvxt"></delect></output>
<video id="zjvxt"><output id="zjvxt"></output></video>

<video id="zjvxt"></video>

<p id="zjvxt"><output id="zjvxt"></output></p>

<video id="zjvxt"><output id="zjvxt"></output></video><video id="zjvxt"></video>
<output id="zjvxt"><output id="zjvxt"></output></output>
<p id="zjvxt"><delect id="zjvxt"><font id="zjvxt"></font></delect></p>

<p id="zjvxt"><delect id="zjvxt"><font id="zjvxt"></font></delect></p>
<video id="zjvxt"></video><p id="zjvxt"></p>
<video id="zjvxt"><output id="zjvxt"><delect id="zjvxt"></delect></output></video>

<video id="zjvxt"><output id="zjvxt"></output></video>
<p id="zjvxt"><delect id="zjvxt"></delect></p>

<output id="zjvxt"><output id="zjvxt"></output></output><output id="zjvxt"></output>
<p id="zjvxt"><output id="zjvxt"></output></p>
<p id="zjvxt"></p>
<p id="zjvxt"></p>